title: Identification and mechanistic studies of a novel ubiquitin E1 inhibitor.
abstract: Protein degradation via the ubiquitin-proteasome pathway is important for a diverse number of cellular processes ranging from cell signaling to development. Disruption of the ubiquitin pathway occurs in a variety of human diseases, including several cancers and neurological disorders. Excessive proteolysis of tumor suppressor proteins, such as p27, occurs in numerous aggressive human tumors. To discover small-molecule inhibitors that potentially prevent p27 degradation, we developed a series of screening assays, including a cell-based screen of a small-molecule compound library and two novel nucleotide exchange assays. Several small-molecule inhibitors, including NSC624206, were identified and subsequently verified to prevent p27 ubiquitination in vitro. The mechanism of NSC624206 inhibition of p27 ubiquitination was further unraveled using the nucleotide exchange assays and shown to be due to antagonizing ubiquitin activating enzyme (E1). We determined that NSC624206 and PYR-41, a recently reported inhibitor of ubiquitin E1, specifically block ubiquitin-thioester formation but have no effect on ubiquitin adenylation. These studies reveal a novel E1 inhibitor that targets a specific step of the E1 activation reaction. NSC624206 could, therefore, be potentially useful for the control of excessive ubiquitin-mediated proteolysis in vivo.
authors.affiliation: University of Colorado, Boulder, Colorado, CO, USA.
authors.forename: Dana
authors.initials: D
authors.lastname: Ungermannova
authors.forename: Seth J
authors.initials: SJ
authors.lastname: Parker
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Nasveschuk
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Chapnick
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Phillips
authors.forename: Robert D
authors.initials: RD
authors.lastname: Kuchta
authors.forename: Xuedong
authors.initials: X
authors.lastname: Liu
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000037:antagonists & inhibitors / Q000378:metabolism; D004220:Disulfides / Q000737:chemistry / Q000494:pharmacology*; D004354:Drug Screening Assays, Antitumor; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D059748:Proteolysis / Q000187:drug effects; D054852:Small Molecule Libraries; D044764:Ubiquitin-Activating Enzymes / Q000037:antagonists & inhibitors*; D054875:Ubiquitination / Q000187:drug effects
chemical_list: D004220:Disulfides; D004791:Enzyme Inhibitors; C573702:NSC624206; D054852:Small Molecule Libraries; D050760:Cyclin-Dependent Kinase Inhibitor p27; D044764:Ubiquitin-Activating Enzymes